Bristol Myers Squibb stock under pressure from patent cliffs

Statements (4)

1. ● Neutral

   Bristol Myers Squibb is trading at a forward earnings multiple of 9.4X

   nasdaq.comOct 3, 2026 07:20 UTC
2. ● Neutral

   Bristol Myers Squibb is trading at a forward earnings multiple of 9.4X

   fool.comOct 3, 2026 07:00 UTC
3. ▼ Bearish

   Bristol Myers Squibb's dividend may face a decline in 2027 due to a patent cliff on its largest cash generator.

   247wallst.comSep 30, 2026 15:45 UTC
4. ● Neutral

   Bristol Myers Squibb's valuation is described as dirt cheap by the media.

   finance.yahoo.comSep 29, 2026 09:41 UTC